文献速递脊柱外科

术前大麻使用对脊柱融合临床结局的影响:系统综述与Meta分析

Impact of Preoperative Cannabis Use on Clinical Outcomes of Spinal Fusion-Systematic Review and Meta-analysis.
PubMed 文献 · Spine (Phila Pa 1976) · 2026-01-20

该系统综述与Meta分析纳入7项回顾性研究共1920例患者(其中386例为大麻使用者),比较术前使用大麻与未使用大麻患者脊柱融合的结局。结果显示大麻组住院期间阿片类药物用量、再入院率和再手术率显著增加,手术并发症未见显著增加。作者认为术前使用大麻可能与较差的手术结局相关,并建议患者被告知相关风险、临床医生应进行筛查,并劝告患者在脊柱融合术前停止或至少减少大麻使用。

要点

  • 大麻组住院期间阿片类药物用量显著增加(MD 58.84 MME;95%CI 29.75-87.93;P<0.01)。
  • 大麻组再入院风险升高(OR 1.70;95%CI 1.01-2.87;P=0.045),再手术风险升高(OR 3.78;95%CI 2.06-6.94;P<0.001)。
  • 研究显示手术并发症未见显著增加。

核心结论

  • 术前使用大麻可能与较差的手术结局相关,包括围手术期阿片类药物使用增加和术后再入院率升高。
  • 作者认为应详细告知患者这些风险,临床医生应进行筛查,并劝告患者在脊柱融合术前停止或至少减少大麻使用,以尽量减少手术并发症。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Scopus、Web of Science和Cochrane Library,纳入比较术前使用大麻与未使用大麻患者脊柱融合结局的研究。
  • 共纳入7项回顾性研究、1920例患者,其中386例为大麻使用者。

主要发现

  • 大麻组住院期间阿片类药物用量显著增加(MD 58.84 MME;95%CI 29.75-87.93;P<0.01)。
  • 大麻组再入院率显著增加(OR 1.70;95%CI 1.01-2.87;P=0.045)。
  • 大麻组再手术率显著增加(OR 3.78;95%CI 2.06-6.94;P<0.001)。
  • 研究显示手术并发症未见显著增加。

临床怎么用

  • 作者认为应详细告知患者术前使用大麻的相关风险,临床医生应进行筛查。
  • 作者劝告患者在脊柱融合术前停止或至少减少大麻使用,以尽量减少手术并发症。

局限性

  • 纳入的7项研究均为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Systematic review and meta-analysis. OBJECTIVE: To explore the impact of preoperative cannabis use on perioperative outcomes of spinal fusion procedures. SUMMARY OF BACKGROUND DATA: Opioid use disorder is a growing problem, especially in the United States. Cannabis use is increasingly being adopted as an alternative method of pain management. However, it remains unclear how a history of preoperative cannabis use impacts opioid consumption, length of hospitalization, or perioperative complications in spinal fusion procedures. METHODS: The authors searched PubMed, Scopus, Web of Science, and Cochrane Library for studies where outcomes of spinal fusion were compared between patients preoperatively exposed and nonexposed to active cannabis use. RESULTS: A total of 7 retrospective studies and 1920 patients (386 cannabis users) were included. Significant increase in in-hospital opioid use (MD 58.84 MME; 95% CI: 29.75-87.93; P <0.01), readmission (OR 1.70; 95% CI: 1.01-2.87; P =0.045), and reoperation (OR 3.78; 95% CI: 2.06-6.94; P <0.001) was observed in the cannabis group. Studies showed no significant increase in surgical complications. CONCLUSION: A history of preoperative cannabis use may be associated with poorer surgical outcomes, including increased perioperative opioid utilization and a higher rate of postoperative hospital readmissions. Patients should be informed in detail about these risks, and clinicians should screen for them. Counsel patients to cease or at least reduce the use of cannabis before a spinal fusion procedure, in order to minimize surgical complications.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Łajczak P, Łajczak A, Pimenta NG, et al. Impact of Preoperative Cannabis Use on Clinical Outcomes of Spinal Fusion-Systematic Review and Meta-analysis. Spine (Phila Pa 1976). 2026. PMID: 41563718. doi:10.1097/BRS.0000000000005621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。